No Benefit Found for COVID-19 Convalescent Plasma in High-Risk Outpatients
Disease progression was not reduced with convalescent plasma for outpatients aged 50 years or older with one or more risk factors
Poverty Tied to Worse Functional Status in Rheumatoid Arthritis
Patients with lower socioeconomic status also have increased probability of functional decline in longitudinal analyses
More Than 10 Percent of Adults Missed Health Care in Spring 2021
In addition, 9.2 percent of parents report delaying or forgoing care for their children for fear of exposure to the coronavirus
Pfizer-BioNTech COVID-19 Vaccine Receives Full FDA Approval
Prescribing information includes warning about risks for myocarditis and pericarditis, particularly in men younger than 40 years
COVID-19 Mortality Lower for Vaccinated Solid Organ Transplant Recipients
Second study shows increased risk for breakthrough COVID-19 infection and associated mortality for SOTRs versus general population
Roxadustat Treats Anemia in Non-Dialysis-Dependent CKD
Pooled data show roxadustat versus placebo increases hemoglobin levels with an acceptable profile for cardiovascular safety
Among Persons With HIV, More Finish Short-Course TB Prophylaxis
Treatment completion 90.4 percent for three months of rifapentine-isoniazid versus 50.5 percent for six months of isoniazid
Israeli Study Shows Pfizer Booster Gives Seniors Big Rise in Immunity
Israel approved booster shots for people aged 60 years and older late last month; the government lowered the age of eligibility to 40 years last week
Pentagon to Make COVID-19 Vaccination Mandatory for Military
Officials are preparing to issue guidance to require vaccination, although no exact timeline has been given
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized
